Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

DARA: Building An Oncology And Supportive Care Specialty Pharma
Yahoo/Zacks.com
Friday, November 15, 2013 - 8:40am
tags:
DARA Biosciences, oncology, earnings
FDA says new cholesterol drugs may not need outcome studies
Yahoo/Reuters
Friday, November 15, 2013 - 8:37am
tags:
FDA, cholesterol, PCSK9 inhibitors, statins, Pfizer, Amgen, Sanofi, Regeneron
Pfizer Ditching BlackBerry, Citing Its ‘Volatile’ State
Bloomberg
Thursday, November 14, 2013 - 5:53pm
tags:
Pfizer, Blackberry
Anacor Rises on Positive Data
Yahoo/Zacks.com
Thursday, November 14, 2013 - 5:52pm
tags:
Anacor, atopic dermatitis, AN2728
U.S. FDA panel backs Vanda's circadian rhythm drug
Yahoo/Reuters
Thursday, November 14, 2013 - 5:50pm
tags:
FDA, advisory panels, Vanda, non-24 hour disorder, tasimelteon
Merck Raises 2013 Profit Forecast on Speed of Cost Cuts
Bloomberg
Thursday, November 14, 2013 - 12:10pm
tags:
Merck, guidance
Trio of IPO setbacks strike sour note at biotech's Wall Street party
Fierce Biotech
Thursday, November 14, 2013 - 11:06am
tags:
biotech, IPOs, Relypsa, Xencor, Celladon
Merck May Lose Out From New Treatment Guide For Cholesterol
Seeking Alpha
Thursday, November 14, 2013 - 11:02am
tags:
Merck, statins, cholesterol, Zetia
Key Takeaways From Arena's Third-Quarter Update
Motley Fool
Thursday, November 14, 2013 - 11:00am
tags:
earnings, Arena Pharmaceuticals, Belviq, Eisai
2013's story: Fewer drug approvals, better-selling drugs
Fierce Pharma
Thursday, November 14, 2013 - 10:58am
tags:
drug approvals
Tandem Diabetes shares surge 30% above IPO price
Mass Device
Thursday, November 14, 2013 - 10:56am
tags:
Tandem Diabetes, devices, diabetes, IPOs
House Legislators Set to Grill FDA on FDASIA Progress
Regulatory Focus
Thursday, November 14, 2013 - 10:55am
tags:
FDA, FDASIA
Teva Rejected by U.S. High Court Justice on Copaxone Patent
Bloomberg
Thursday, November 14, 2013 - 10:54am
tags:
patents, Copaxone, Teva, Supreme Court, MS, multiple sclerosis
The Perfect Storm: Will The Mess At Teva Lead To A Merger?
Pharmalot
Thursday, November 14, 2013 - 10:44am
tags:
M&A, Teva
Diabetes battle "being lost" as cases hit record 382 mln
Yahoo/Reuters
Thursday, November 14, 2013 - 10:36am
tags:
diabetes, China, type 2 diabetes
Generic Drugs Seen Limited in WikiLeaks Trade Document
Bloomberg
Thursday, November 14, 2013 - 10:34am
tags:
generics, trade agreement, WikiLeaks
Watch The R&D Chiefs Of Pfizer, Merck, And Amgen Discuss The Drug Industry's Challenges
Forbes
Thursday, November 14, 2013 - 10:31am
tags:
R&D, Pfizer, Amgen, Merck
A SWOT Analysis Of AstraZeneca Plc And GlaxoSmithKline plc
Motley Fool
Thursday, November 14, 2013 - 10:30am
tags:
AstraZeneca, GSK
Eli Lilly to invest $700M to enhance global insulin manufacturing capacity
Yahoo/Fly on the Wall
Thursday, November 14, 2013 - 10:29am
tags:
Eli Lilly, drug manufacturing, insulin, diabetes
Intercept Pharma 3Q loss jumps on bigger charges
Yahoo/AP
Thursday, November 14, 2013 - 10:19am
tags:
earnings, Intercept Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.